CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-28 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2018-11-28 | File Justin J. Chief Financial Officer | Grant or award · Stock option (right to buy) | +103,500 | 103,500 | ||
| 2018-11-28 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock option (right to buy) | +284,625 | 284,625 | ||
| 2018-11-28 | Barrans Russell Chief Commercial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2018-11-28 | Culwell Kelly Chief Medical Officer | Grant or award · Common Stock | +100,000 | 100,000 | ||
| 2018-11-28 | Barrans Russell Chief Commercial Officer | Grant or award · Stock option (right to buy) | +0 | 100,000 | ||
| 2018-11-28 | File Justin J. Chief Financial Officer | Grant or award · Stock option (right to buy) | +0 | 103,500 | ||
| 2018-11-28 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award · Stock option (right to buy) | +0 | 100,000 | ||
| 2018-11-28 | Culwell Kelly Chief Medical Officer | Grant or award · Common Stock | +0 | 100,000 | ||
| 2018-11-28 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock option (right to buy) | +0 | 284,625 | ||
| 2018-11-21 | Barrans Russell Chief Commercial Officer | Purchase | +279 | $3.55 | $990 | 12,820 |
| 2018-10-16 | Fitzpatrick Alexander A General Counsel and Secretary | Shares withheld for taxes | −17,377 | $3.78 | $66K | 57,623 |
| 2018-08-21 | Fitzpatrick Alexander A General Counsel and Secretary | Purchase | +500 | $2.27 | $1K | 75,000 |
| 2018-08-20 | Fitzpatrick Alexander A General Counsel and Secretary | Purchase | +4,500 | $2.20 | $10K | 74,500 |
| 2018-08-16 | Culwell Kelly Chief Medical Officer | Purchase | +3,000 | $2.24 | $7K | 11,985 |
| 2018-08-15 | Lynch Thomas G Director | Purchase | +68,929 | $2.33 | $161K | 175,000 |
| 2018-08-14 | Lynch Thomas G Director | Purchase | +31,071 | $2.10 | $65K | 106,071 |
| 2018-08-10 | Barrans Russell Chief Commercial Officer | Purchase | +3,715 | $1.98 | $7K | 12,541 |
| 2018-08-10 | PELLETIER SAUNDRA L Chief Executive Officer | Purchase | +10,000 | $2.11 | $21K | 341,813 |
| 2018-07-31 | Rutherford Colin Director | Grant or award · Stock option (right to buy) | +0 | 5,550 |
Page 10 of 20 · 383 trades